Bristi Basu, MD

Articles by Bristi Basu, MD

Dr. Basu on Second-Line Therapy in HCC

September 27th 2018

Bristi Basu, MD, honorary consultant medical oncologist, University of Cambridge, discussed second-line therapy for patients with hepatocellular carcinoma.

Latest Updated Articles

Dr. Basu on Second-Line Therapy in HCC
September 27th 2018

Bristi Basu, MD

Articles by Bristi Basu, MD

Dr. Basu on Second-Line Therapy in HCC

Latest Updated Articles

Trending on OncLive

FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC

PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings

Olverembatinib Plus Blinatumomab Yields High Early-Phase CR/CRi Rates in R/R Ph+ CML and B-ALL

Dr Falchi on Critical Unmet Needs and Important Next Steps in DLBCL

Sonrotoclax and Next-Generation BCL-2 Inhibitors for Treating CLL